1h Free Analyst Time
The glycobiology market is forecasted to grow by USD 2.21 billion during 2023-2028, accelerating AT a CAGR of 18.52% during the forecast period. The report on the glycobiology market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of cancer, increase in expenditure by different pharmaceutical companies on r and D, and increasing government and private funding for glycomics and proteomics research.
The glycobiology market is segmented as below:
By Application
- Drug discovery and development
- Disease diagnostics
- Others
By Product
- Enzymes
- Instruments
- Reagents
- Kits
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the glycobiology market covers the following areas:
- Glycobiology market sizing
- Glycobiology market forecast
- Glycobiology market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Product
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global glycobiology market: Agilent Technologies Inc., Asparia Glycomics, Bio Techne Corp., Bruker Corp., CD BioGlyco, Chemily Glycoscience, Genovis AB, ICE S.p.a., Lectenz Bio, Ludger Ltd., Merck KGaA, NEW England Biolabs Inc., NZYTech, Plexera LLC, Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corp., and ZBiotech.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advancements in field of glycobiology."
According to the report, one of the major drivers for this market is the growing prevalence of cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Asparia Glycomics
- Bio Techne Corp.
- Bruker Corp.
- CD BioGlyco
- Chemily Glycoscience
- Genovis AB
- ICE S.p.a.
- Lectenz Bio
- Ludger Ltd.
- Merck KGaA
- New England Biolabs Inc.
- NZYTech
- Plexera LLC
- Shimadzu Corp.
- Sumitomo Bakelite Co. Ltd.
- Takara Bio Inc.
- Thermo Fisher Scientific Inc.
- Waters Corp.
- ZBiotech
